Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	790.37	275.30	-30.92
Graham Fair Price	-75.71	1.03	4.24
PEG	6336.40	-1.05	0.02
Price/Book	-4.62	1.21	1.27
Price/Cash Flow	-12.44	-91.60	-81.46
Prices/Earnings	1526.22	111.49	-6.86
Price/Sales	67.74	2.63	1.57
Price/FCF	-12.44	-91.60	-81.46
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-21.21	0.08	0.10
Operating Margin	-83.71	0.01	-0.08
ROA	-94.10	< 0.005	-0.02
ROE	-0.05	< 0.005	-94.14
ROIC	-0.03	< 0.005	-92.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-79.32
Dividends QOQ	-0.89	-0.05	94.15
EBIT QOQ	-5.30	1.09	-79.40
EPS QOQ	-4.19	1.06	-74.73
FCF QOQ	0.83	0.15	-81.79
Revenue QOQ	0.48	-0.43	-11.04
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	18.44	26.74	45.02
Days Sales Outstanding (DSO)	20.41	40.29	97.41
Inventory Turnover	4.88	3.37	-31.04
Debt/Capitalization	0.47	0.47	1.39
Quick Ratio	0.48	0.49	1.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.15	4.16	0.28
Cash	1.09	1.11	1.33
Capex	0.13	-0.18	37.61
Free Cash Flow	-0.06	-0.06	14.94
Revenue	3.37	1.92	-42.98
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.68	0.66	-2.24
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.30	94.82	820.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating